Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)

ConclusionsSarcosine does not significantly affect IL‐6 concentrations but IL‐6 may be involved in mechanisms related to the presence of positive symptoms.

Source: Human Psychopharmacology: Clinical and Experimental - February 7, 2018 Category: Psychiatry Authors: Dominik Strzelecki, Ma łgorzata Urban‐Kowalczyk, Adam Wysokiński Tags: RESEARCH ARTICLE Source Type: research